Publication | Closed Access
OA12.05 Vemurafenib in Patients Harboring V600 and Non V600 BRAF Mutations: Final Results of the NSCLC Cohort from the AcSé Trial.
11
Citations
0
References
2018
Year
Oa12.05 VemurafenibGenetic DisorderMedicinePharmacologyClinical TrialsPathologyGenetic EpidemiologyPharmacotherapyMedical GeneticsMolecular DiagnosticsAcsé TrialMolecular OncologyNsclc CohortClinical Genetics
No additional data available for this publication yet. Check back later!